Literature DB >> 28260835

Psychometric Properties of the Generalized Anxiety Disorder Scale-7 (GAD-7) in Outpatients with Anxiety and Mood Disorders.

Lauren A Rutter1, Timothy A Brown1.   

Abstract

Entities:  

Year:  2016        PMID： 28260835      PMCID： PMC5333929          DOI： 10.1007/s10862-016-9571-9

Source DB:  PubMed          Journal:  J Psychopathol Behav Assess        ISSN： 0882-2689


× No keyword cloud information.
  26 in total

1.  Confirmatory factor analysis of the Penn State Worry Questionnaire: Multiple factors or method effects?

Authors:  Timothy A Brown
Journal:  Behav Res Ther       Date:  2003-12

Review 2.  Generalized anxiety and mixed anxiety-depression: association with disability and health care utilization.

Authors:  P P Roy-Byrne
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

3.  Psychometric properties and construct validity of the Obsessive-Compulsive Inventory--Revised: Replication and extension with a clinical sample.

Authors:  Jonathan S Abramowitz; Brett J Deacon
Journal:  J Anxiety Disord       Date:  2006-04-18

Review 4.  Human and economic burden of generalized anxiety disorder.

Authors:  Deborah L Hoffman; Ellen M Dukes; Hans-Ulrich Wittchen
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

5.  Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample.

Authors:  T A Brown; L A Campbell; C L Lehman; J R Grisham; R B Mancill
Journal:  J Abnorm Psychol       Date:  2001-11

6.  The psychometric properties of the generalized anxiety disorder-7 scale in Hispanic Americans with English or Spanish language preference.

Authors:  Sarah D Mills; Rina S Fox; Vanessa L Malcarne; Scott C Roesch; Brian R Champagne; Georgia Robins Sadler
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2014-07

7.  Brief case finding tools for anxiety disorders: validation of GAD-7 and GAD-2 in addictions treatment.

Authors:  Jaime Delgadillo; Scott Payne; Simon Gilbody; Christine Godfrey; Stuart Gore; Dawn Jessop; Veronica Dale
Journal:  Drug Alcohol Depend       Date:  2012-04-04       Impact factor: 4.492

8.  Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Patrick O Monahan; Bernd Löwe
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

9.  Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care.

Authors:  Miguel A Ruiz; Enric Zamorano; Javier García-Campayo; Antonio Pardo; Olga Freire; Javier Rejas
Journal:  J Affect Disord       Date:  2010-08-09       Impact factor: 4.839

10.  Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population.

Authors:  Bernd Löwe; Oliver Decker; Stefanie Müller; Elmar Brähler; Dieter Schellberg; Wolfgang Herzog; Philipp Yorck Herzberg
Journal:  Med Care       Date:  2008-03       Impact factor: 2.983
View more
  58 in total

1.  The Contribution of Worry Behaviors to the Diagnosis of Generalized Anxiety Disorder.

Authors:  Timothy A Brown; Esther S Tung
Journal:  J Psychopathol Behav Assess       Date:  2018-05-10

2.  Implementation of the Bergen 4-Day Treatment for Obsessive Compulsive Disorder in Iceland.

Authors:  Sóley Dröfn Davíðsdóttir; Ólafía Sigurjónsdóttir; Sigurbjörg Jóna Ludvigsdóttir; Bjarne Hansen; Inger Lill Laukvik; Kristen Hagen; Thröstur Björgvinsson; Gerd Kvale
Journal:  Clin Neuropsychiatry       Date:  2019-02

3.  HIV, substance use, and intersectional stigma: Associations with mental health among persons living with HIV who inject drugs in Russia.

Authors:  Kimberly Hook; Yuliia Sereda; Sarah Rossi; Sarah Koberna; Marina V Vetrova; Sara Lodi; Karsten Lunze
Journal:  AIDS Behav       Date:  2022-08-01

4.  Stress and anxiety among physicians during the COVID-19 outbreak in the Iraqi Kurdistan Region: An online survey.

Authors:  Banaz A Saeed; Nazar P Shabila; Aram Jalal Aziz
Journal:  PLoS One       Date:  2021-06-29       Impact factor: 3.240

5.  A Sequential Multiple Assignment Randomized Trial (SMART) study of medication and CBT sequencing in the treatment of pediatric anxiety disorders.

Authors:  Bradley S Peterson; Amy E West; John R Weisz; Wendy J Mack; Michele D Kipke; Robert L Findling; Brian S Mittman; Ravi Bansal; Steven Piantadosi; Glenn Takata; Corinna Koebnick; Ceth Ashen; Christopher Snowdy; Marie Poulsen; Bhavana Kumar Arora; Courtney M Allem; Marisa Perez; Stephanie N Marcy; Bradley O Hudson; Stephanie H Chan; Robin Weersing
Journal:  BMC Psychiatry       Date:  2021-06-30       Impact factor: 3.630

6.  Validation of brief screening measures for depression and anxiety in young people with substance use disorders.

Authors:  Kate H Bentley; Hitoshi Sakurai; Kelsey L Lowman; Lisa Rines-Toth; James McKowen; Paola Pedrelli; A Eden Evins; Amy M Yule
Journal:  J Affect Disord       Date:  2021-01-07       Impact factor: 4.839

Review 7.  Assessing health-related quality of life among patients with peripheral artery disease: A review of the literature and focus on patient-reported outcome measures.

Authors:  Aishwarya Raja; John Spertus; Robert W Yeh; Eric A Secemsky
Journal:  Vasc Med       Date:  2020-12-09       Impact factor: 3.239

8.  Treatment Adherence as Predictor of Outcome in Concentrated Exposure Treatment for Obsessive-Compulsive Disorder.

Authors:  Kristian Tjelle; Håvard Berg Opstad; Stian Solem; Gunvor Launes; Bjarne Hansen; Gerd Kvale; Kristen Hagen
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

9.  COVID-19 pandemic related long-term chronic stress on the prevalence of depression and anxiety in the general population.

Authors:  Tian Qi; Ting Hu; Qi-Qi Ge; Xiao-Na Zhou; Jia-Mei Li; Chun-Lei Jiang; Wei Wang
Journal:  BMC Psychiatry       Date:  2021-07-28       Impact factor: 3.630

10.  Anxious distress in depressed outpatients: Prevalence, comorbidity, and incremental validity.

Authors:  Anthony J Rosellini; Michelle L Bourgeois; Jeannette Correa; Esther S Tung; Svetlana Goncharenko; Timothy A Brown
Journal:  J Psychiatr Res       Date:  2018-05-08       Impact factor: 4.791
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.